J.Ten KulveJ
The safety and efficacy of growth hormone secretagogues
Western blot results demonstrated that the expression of the odonto/osteogenic proteins (DMP1, COL-I, ALP, RUNX2, OSX, DSP and OCN) was significantly decreased in IGF-1 treated SCAPs accompanying with the over-expression of hsa-let-7c , in which the expression of RUNX2 and DSP kept reducing from day 3 to day 7, and the expression of DMP1, COL-I, ALP, OSX and OCN obviously decreased at day 7 (Fig
Ipamorelin, the first selective growth hormone secretagogue Raun K, Hansen BS, Johansen NL, et al
7 Discussion GLP-1 RAs have shown effects beyond their initial application in managing T2DM
However, GH levels may gradually return to baseline over time